Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

Update Il y a 4 ans
Reference: NCT01122771

Woman and Man

  • | Country :
  • Bangladesh
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This protocol will evaluate the efficacy and safety of various combinations of the three drugs; AmBisome, Paromomycin and Miltefosine at reduced total dosage against the standard treatment with a total dose of 15mg/kg of AmBisome.


Inclusion criteria

  • Visceral leishmaniasis

Links